Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerEffect of a chemical inhibitor of human phosphatidylethanolamine-binding protein 4 on radiosensitivity of rectal cancer cellsProteomics, morphoproteomics, saliva and breast cancer: an emerging approach to guide the delivery of individualised thermal therapy, thermochemotherapy and monitor therapy response.PSMD9 expression predicts radiotherapy response in breast cancer.The interconnectedness of cancer cell signaling.Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approachRadioresistance of prostate cancer cells with low proteasome activity.Proteomic Analysis Implicates Dominant Alterations of RNA Metabolism and the Proteasome Pathway in the Cellular Response to Carbon-Ion IrradiationBreast cancer subtypes: response to radiotherapy and potential radiosensitisation.The War on Cancer rages on.Isogenic radiation resistant cell lines: development and validation strategies.Putative biomarkers and therapeutic targets associated with radiation resistance.Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.Homogenous and Microbeam X-Ray Radiation Induces Proteomic Changes in the Brains of Irradiated Rats and in the Brains of Nonirradiated Cage Mate Rats.Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.
P2860
Q24628746-29F12422-502C-44DE-834F-34D9BF2B96E7Q28829353-39267A6E-6E59-40FB-B121-AFA50E5BF2BCQ33694698-AE3BA75E-1B26-429E-818F-D4320234AE85Q34501422-10CA21E8-8C13-4194-94CD-5A4115423C58Q35669733-3F8CAD2E-276F-40B6-833C-973A30B2BF6BQ35744617-754DBD40-BCD9-4480-A36E-C2D838218C0EQ36094487-F12895A4-BC73-4154-8961-BCD74901575BQ36155419-C5C6F89A-04BE-418A-83B6-B93DB7266957Q36715983-0213141C-CF06-41F1-9B90-B7BBA0CDDEE0Q37478602-6087D5D2-593B-49D0-A2AC-4B336FB29F84Q38172298-1CFF7C87-7A50-4C28-B656-89A32CFB589EQ38190630-48ED56CC-252F-4C6F-BEF3-08BBE6AB130AQ39070920-5E9F7D71-0689-4673-8F86-8F93F789905BQ47830585-83CCB5FB-4C91-4EA8-8DE9-78464E4B27B7Q55379488-F302BCE1-4EE3-4E4E-B60D-89BCDD9EC5B4
P2860
Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proteomic identification of pu ...... e role for the 26S proteasome?
@ast
Proteomic identification of pu ...... e role for the 26S proteasome?
@en
Proteomic identification of pu ...... e role for the 26S proteasome?
@nl
type
label
Proteomic identification of pu ...... e role for the 26S proteasome?
@ast
Proteomic identification of pu ...... e role for the 26S proteasome?
@en
Proteomic identification of pu ...... e role for the 26S proteasome?
@nl
prefLabel
Proteomic identification of pu ...... e role for the 26S proteasome?
@ast
Proteomic identification of pu ...... e role for the 26S proteasome?
@en
Proteomic identification of pu ...... e role for the 26S proteasome?
@nl
P2093
P2860
P356
P1433
P1476
Proteomic identification of pu ...... e role for the 26S proteasome?
@en
P2093
Andrew W Beavis
Donna Potts
Kevin J Welham
Laura Smith
Lynn Cawkwell
Mark B Watson
Michael J Lind
Omar Qutob
Philip J Drew
Veerabhadram Garimella
P2860
P304
P356
10.1593/NEO.09902
P577
2009-11-01T00:00:00Z